This article was in the NZ Herald today, you can see it on their website here written by Chris Barton.
A coroner has strongly criticised the care provided by a specialist youth mental health unit leading up to the suicide of 17-year-old Toran Henry.
Auckland Coroner Murray Jamieson said Marinoto Child and Adolescent Mental Health Services’ care of the teenager “was deficient on occasion and in particular on the day of his death”.
His remarks were included in the findings of the inquest into Toran’s death on March 20, 2008. The report was issued yesterday.
Dr Jamieson was critical that, in the face of escalating developments on the day of Toran’s death, the Waitemata District Health Board’s service left his care in the hands of a relatively inexperienced “key worker” who spoke to Toran by phone.
“Toran stated, that day, that he lost faith in one of his key workers, feeling that she had abused his trust,” said the coroner.
He said the situation would have been better dealt with by immediate consultation with a specialist psychiatrist, who could have taken direct action “such as arranging an urgent home visit together with immediate admission to a secure facility if required”.
There was criticism, too, of the way Toran had been prescribed the anti-depressant drug fluoxetine, better known as Prozac, which is not approved for treating major depressive disorders in children and adolescents in New Zealand. But it can be given to that age group by what is known as “off label” prescribing, which requires informed consent from the patient.
Dr Jamieson said the information given to Toran about the drug was not satisfactory. It was not a single comprehensive document, not up to date, not designed for a person of Toran’s age and did not include clear advice about taking the drug in combination with alcohol or other drugs.
He recommended that Marinoto should review the information provided to adolescents, especially the importance of taking the medication as prescribed.
The coroner was also critical of the last occasion Toran was prescribed fluoxetine, at a cafe near Marinoto early in March 2008, by a registrar in psychiatry who had not met Toran or his mother, Maria Bradshaw, before.
The coroner said the consultation should have been carried out by a specialist psychiatrist “fully apprised of the history and clinical picture at a venue appropriate for such an important clinical encounter”.
Dr Jamieson did not make any finding on whether taking the drug contributed to Toran’s death.
Although the question came up during the inquest, the coroner has not addressed concerns that the drug packets in New Zealand do not carry a “Black Box” warning as required by the Food and Drug Administration in the United States. The warning explicitly states that “anti-depressants increased the risk compared to placebo of suicidal thinking and behaviour in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric disorders”.
Malaga a le Pasifika, the cultural support service of Marinoto, was also criticised for the way it attempted, but failed, to organise a meeting between Toran and his father, Geoffrey Henry, a Cook Islander, whom Toran had not seen since he was 14 months old.
The coroner concluded that the circumstances relevant to Toran’s death were:
* The career plan that Toran had set his heart on in early 2008 had proved impractical.
* Toran had been reminded of the absence and apparent rejection of him by his father.
* His relationship with his mother had been tense.
* His relationship with his girlfriend had recently been unhappy.
* The day before his death he had been humiliated in front of many peers when he was involved in a brief fight with a younger Takapuna Grammar School student.
* His abuse of alcohol clouded his judgment.
Clinical director of Mental Health and Addiction Services at Waitemata Murray Patton said a new fluoxetine information sheet had been developed for adolescents and children.
Marinoto clinical staff have also undertaken training to ensure all service users and families have knowledge of common and serious side-effects of psychiatric medicine and how to monitor for them.
About 540 people a year take their own lives – many more than last year’s road toll. More than 2500 New Zealanders are admitted to hospital each year through intentional self-harm.
Age range for 2009/2010:
DISAPPOINTED MOTHER QUESTIONS CORONERS FINDINGS
This linked article can be found here on NZ herald site and is also written by Chris Barton
Toran Henry’s mother, Maria Bradshaw, is disappointed with the findings into her son’s death.
“Was it worth $70,000 to get a [coroner’s] finding where the only recommendation made was that children should take their medication?”
Mrs Bradshaw is yet to learn whether she will get legal aid to cover some of the cost of her legal counsel at the inquest. She has had to sell her house to cover her costs to date and says she will file a complaint about the inquest.
She says she is particularly concerned that the coroner appeared to dismiss arguments during the inquest that selective serotonin reuptake inhibitors (SSRI) – the class of drugs which includes Prozac – were not associated with suicide. She said the coroner did not clearly lay out the reasons for his findings or why he favoured some evidence over others, particularly about the drug’s side effects on Toran. “I just don’t feel that it has been thorough,” she said.
Mrs Bradshaw finds it difficult to comprehend that the coroner finds no criticisms of anyone at Takapuna Grammar. “When they called the police on the day before Toran died to report the fight outside the school, they didn’t mention to the police Toran was under the care of mental health services.
// They didn’t call me … I would have thought that might have attracted some comment from the coroner because that was another opportunity that this could have been prevented.”
Torans Mother is speaking at a Public Mental Wealth learning day coming up 29th October. I will post details in the next post, contact Psychiatric survivors if you are interested to attend on 021-206 8759 and on (09) 846-9945